FRA
RGEN icon

Front Row Advisors’s Repligen RGEN Stock Holding History

Front Row Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41K Hold
12
– – ﹤0.01% 520
2025
Q4 		$1.97K Hold
12
– – ﹤0.01% 487
2025
Q3 		$1.6K Sell
12
-6
-33% -$729 ﹤0.01% 497
2025
Q2 		$2.24K Sell
18
-12
-40% -$1.53K ﹤0.01% 468
2025
Q1 		$3.82K Hold
30
– – ﹤0.01% 423
2024
Q4 		$4.32K Hold
30
– – ﹤0.01% 416
2024
Q3 		$4.46K Hold
30
– – ﹤0.01% 415
2024
Q2 		$3.78K Hold
30
– – ﹤0.01% 776
2024
Q1 		$5.52K Hold
30
– – ﹤0.01% 707
2023
Q4 		$5.39K Hold
30
– – ﹤0.01% 371
2023
Q3 		$4.77K Hold
30
– – ﹤0.01% 682
2023
Q2 		$4K Hold
30
– – ﹤0.01% 720
2023
Q1 		$5K Buy
+30
New +$5.35K ﹤0.01% 684

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Front Row Advisors's RGEN Position: Q1 2026 in Review

Front Row Advisors held its Repligen (RGEN) position steady in Q1 2026 at 12 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

Front Row Advisors first reported a position in RGEN in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.52K in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Front Row Advisors held 12 shares of Repligen worth $1.41K as of Q1 2026.
  • Front Row Advisors left its Repligen share count unchanged in Q1 2026.
  • Repligen made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #520 holding.
  • Front Row Advisors first reported a position in Repligen in Q1 2023 and has held it in 13 quarters since.
  • Front Row Advisors's Repligen position peaked at $5.52K in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.